Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Roman N Rodionov - , University Hospital Carl Gustav Carus Dresden (Author)
Anne Biener - , Department for Cardiosurgery (at Herzzentrum Dresden), University Hospital Carl Gustav Carus Dresden (Author)
Peter Spieth - , Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus Dresden (Author)
Martin Achleitner - , Department of internal Medicine 3, Institute for Immunology, University Hospital Carl Gustav Carus Dresden (Author)
Kristina Hölig - , University Hospital Carl Gustav Carus Dresden (Author)
Martin Aringer - , Department of internal Medicine 3, University Hospital Carl Gustav Carus Dresden (Author)
Geltrude Mingrone - , Catholic University of the Sacred Heart (Author)
Victor M Corman - , Charité – Universitätsmedizin Berlin (Author)
Christian Drosten - , Charité – Universitätsmedizin Berlin (Author)
Stefan R Bornstein - , Department of internal Medicine 3, University Hospital Carl Gustav Carus Dresden, School of Life Course Sciences, King's College London (KCL) (Author)
Torsten Tonn - , Division Transfusion Medicine, Department of internal Medicine I, University Hospital Carl Gustav Carus Dresden, TUD Dresden University of Technology, DRK Blutspendendienst Nord Ost gGmbH (Author)
Martin Kolditz - , Department of internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)

Blood Component Transfusion, COVID-19/therapy, Humans, Immunization, Passive, Immunocompromised Host, Plasma, COVID-19 Serotherapy